News
MSD – known as Merck & Co in the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has been ...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Merck pulled off its $10 billion buyout of Verona Pharma last month with little of the wheeling and dealing that typically ...
The UK’s National Institute for Health and Care Excellence (NICE) on August 6 recommended the use of US pharma giant Merck & ...
Summit Therapeutics Inc.'s valuation hinges on ivonescimab's potential, yet the data, competition, and regulatory issues ...
Meanwhile, mRNA vaccine maker Moderna is cutting around 500 jobs (10% of its workforce) as part of a commitment to save $1.5 ...
The highest-paying dividend stocks in the Dow Jones Industrial Average right now are Verizon Communications (NYSE: VZ), ...
President Trump escalated pressure on the pharmaceutical industry last week by sending letters to 17 major drug companies ...
MRK scores an A+ grade for Profitability, aided by high gross and EBITDA margins of 78% and 46%, respectively. Moreover, it ...
Thousands of women battling an advanced form of womb cancer have been offered renewed hope after a new treatment was approved for widespread use on the NHS. At such a critical moment in US history, we ...
Antibody-drug conjugates are currently being investigated in more than 260 clinical trials.“It’s going to be the next novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results